TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) - No Study Results Posted

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) (TTEDD)

This study is ongoing, but not recruiting participants.

Study NCT00451321 Information provided by GlaxoSmithKline

First Received: March 21, 2007 Last Updated: October 6, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2014
Estimated Primary Completion Date:	April 2014 (Final data collection date for primary outcome measure)